Skip to main content
Erschienen in:

01.03.2023 | Case report

Ad26.cov2-s/tozinameran

Transient tachycardia and pseudoseizure: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Auszug

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Lyons D, et al. Risk stratification through allergy history: single-centre experience of specialized COVID-19 vaccine clinic. Clinical and Experimental Immunology 209: 182-187, No. 2, Aug 2022. Available from: URL: https://academic.oup.com/cei/issue Lyons D, et al. Risk stratification through allergy history: single-centre experience of specialized COVID-19 vaccine clinic. Clinical and Experimental Immunology 209: 182-187, No. 2, Aug 2022. Available from: URL: https://​academic.​oup.​com/​cei/​issue
Metadaten
Titel
Ad26.cov2-s/tozinameran
Transient tachycardia and pseudoseizure: 2 case reports
Publikationsdatum
01.03.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-35577-7